Cutera Osake

Cutera EBITDA

Delisted

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cutera (CUTRQ) 9.9.2026 päivämäärällä on −156,23 M USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −38,20 M USD — muutos 308,98 % (matalampi).

EBITDA

−156,23 MUSD

YoY

308,98%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cutera on 2026 −156,23 M USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cutera oli 2025 −38,20 M USD. Se laskee 308,98% matalampi edelliseen vuoteen verrattuna.

Cutera EBITDA historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

EBITDA
Date
EBITDA
1.1.2016
2,40 M USD
1.1.2017
7,10 M USD
1.1.2018
−13,40 M USD
1.1.2019
−12,10 M USD
1.1.2020
−22,80 M USD
1.1.2021
2,00 M USD
1.1.2022
−38,20 M USD
1.1.2023
−156,23 M USD
Cutera EBITDA historia
VUOSIEBITDAYoY
−156,23 MUSD+308,98%
−38,20 MUSD−2 010,00%
2,00 MUSD−108,77%
−22,80 MUSD+88,43%
−12,10 MUSD−9,70%
−13,40 MUSD−288,73%
7,10 MUSD+195,83%
2,40 MUSD−153,33%
−4,50 MUSD−57,55%
−10,60 MUSD
Access this data via the Eulerpool API

Cutera Osakeanalyysi

Mitä Cutera tekee? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Cutera osakkeesta

Yhtiön Cutera EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −156,23 M USD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cutera muuttui arvosta −38,20 M USD arvoon −156,23 M USD, mikä edustaa 308,98 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Cutera:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Cutera historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Cutera

Kaikki tunnusluvut — Cutera